Multicenter Phase II Trial of Motexafin Gadolinium and Pemetrexed for Second-Line Treatment in Patients with Non-small Cell Lung Cancer
Keywords: موتسافین گادولینیم; Lung cancer; Motexafin gadolinium; Pemetrexed; Second line